Healthcare provider profile · identity verified

Kimberly Lewis, MD

Family Practice · DARTMOUTH, MA · NPI 1235622960

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	401	119
Amlodipine Besylate	Amlodipine Besylate	222	67
Lisinopril	Lisinopril	200	62
Omeprazole	Omeprazole	195	52
Metformin Hcl	Metformin Hcl	176	44
Levothyroxine Sodium	Levothyroxine Sodium	172	45
Trazodone Hcl	Trazodone Hcl	132	27
Gabapentin	Gabapentin	120	30
Simvastatin	Simvastatin	116	29
Pantoprazole Sodium	Pantoprazole Sodium	105	25
Albuterol Sulfate Hfa	Albuterol Sulfate	103	29
Fluticasone Propionate	Fluticasone Propionate	103	37
Rosuvastatin Calcium	Rosuvastatin Calcium	100	34
Losartan Potassium	Losartan Potassium	97	33
Metoprolol Succinate	Metoprolol Succinate	96	26
Metoprolol Tartrate	Metoprolol Tartrate	83	22
Sertraline Hcl	Sertraline Hcl	81	23
Hydrochlorothiazide	Hydrochlorothiazide	74	27
Pravastatin Sodium	Pravastatin Sodium	68	22
Quetiapine Fumarate	Quetiapine Fumarate	50	suppressed
Furosemide	Furosemide	49	suppressed
Alendronate Sodium	Alendronate Sodium	48	12
Duloxetine Hcl	Duloxetine Hcl	40	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	40	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	38	suppressed
Baclofen	Baclofen	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Haloperidol	Haloperidol	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Glipizide	Glipizide	28	11
Propranolol Hcl Er	Propranolol Hcl	28	suppressed
Allopurinol	Allopurinol	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Meloxicam	Meloxicam	24	suppressed
Clozapine	Clozapine	23	suppressed
Divalproex Sodium	Divalproex Sodium	23	suppressed
Raloxifene Hcl	Raloxifene Hcl	23	suppressed
Potassium Chloride	Potassium Chloride	22	suppressed
Eliquis	Apixaban	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Carvedilol	Carvedilol	19	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Nystatin	Nystatin	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Risperidone	Risperidone	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Lithium Carbonate Er	Lithium Carbonate	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Famotidine	Famotidine	15	suppressed
Naproxen	Naproxen	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Atenolol	Atenolol	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Olanzapine Odt	Olanzapine	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error